U.S. Markets close in 2 hrs 55 mins

Form 8.3 -


                FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) State Street Global Advisors & Affiliates
Company dealt in AbbVie Inc.
Class of relevant security to which
the dealings being disclosed relate
(Note 2)
US$0.01 common stock
Date of dealing 15th January 2020

 
   

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

  Long Short
  Number (%) Number (%)
(1) Relevant securities 68,993,600

 

 

 

 
4.66516%

 

 

 

 

 

 

 
   
(2) Derivatives (other than options) N/A      
(3) Options and agreements to
purchase/sell
N/A      
Total 68,993,600

 

 

 

 
4.66516%

 

 

 

 

 

 

 
   

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
  Number (%) Number (%)
(1) Relevant securities N/A      
(2) Derivatives (other than options) N/A      
(3) Options and agreements to purchase/sell N/A      
Total N/A      

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit (Note 5)
Purchase 400 89.26
Purchase 200 89.26
Purchase 4,100 89.26
Purchase 27,500 89.26
Purchase 186 89.26
Purchase 1,035 88.77
Purchase 23,820 89.26
Purchase 464 89.26
Purchase 672 89.26
Purchase 7,600 89.26
Purchase 18,600 89.26
Purchase 22,785 89.26
Purchase 309 89.26
Purchase 52 89.26
Purchase 536 89.26
Purchase 536 89.26
Purchase 115 89.57
Purchase 1,000 88.52
Sale 200 89.26
Sale 41,200 89.26
Sale 4,530 89.26
Sale 513 89.26
Sale 400 89.26
Sale 4,100 89.26
Sale 100 89.26
Sale 99,680 89.26
Sale 99 89.26
Sale 18,668 89.26

 (b) Derivatives transactions (other than options transactions)

Product name,
e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)
N/A      

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,
e.g. call option
Writing, selling,
purchasing
 varying etc.
Number of
securities to which
the option relates
(Note 7)
Exercise
price
Type, e.g.
American,
European etc.
Expiry
date
Option money
paid/received
per unit
(Note 5)
N/A            

(ii) Exercising

Product name,
e.g. call option
Number of securities Exercise price per
unit
(Note 5)
N/A    

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction
(Note 8)
Details Price per unit
(if applicable)
(Note 5)
N/A    

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
N/A


Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure 16th January 2020

 
Contact name Lionel Colaco
Telephone number                                                             020 33956098
If a connected EFM, name of offeree/offeror with which connected N/A
If a connected EFM, state nature of connection (Note 10) N/A